{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:49:25Z","timestamp":1791416965096,"version":"4.3.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06373-5","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:25:43Z","timestamp":1784003143000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Neuroleptic malignant syndrome precipitated by chlorpromazine: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Abdirahman Abdikadir","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein Mahdi","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Abdulrahman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0596-1106","authenticated-orcid":false,"given":"Abdisalam Ismail","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Yusuf","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Muhammad","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Farah Osman","family":"Hidig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian Muse","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"6373_CR1","unstructured":"Neuroleptic Malignant Syndrome - StatPearls - NCBI Bookshelf. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482282\/. Accessed 8 Dec 2025."},{"key":"6373_CR2","first-page":"1","volume":"37","author":"S St\u00fcbner","year":"2004","unstructured":"St\u00fcbner S, Rustenbeck E, Grohmann R, Wagner C, Engel R, Neund\u00f6rfer C, et al. Severe and uncommon involuntary movement disorders due to psychotropic drugs. Pharmacopsychiatry. 2004;37:1.","journal-title":"Pharmacopsychiatry"},{"key":"6373_CR3","first-page":"3","volume":"14","author":"T Paul","year":"2022","unstructured":"Paul T, Karam A, Paul T, Loh H, Ferrer GF, Paul T, et al. A case report on neuroleptic malignant syndrome (NMS): how to approach an early diagnosis. Cureus. 2022;14:3.","journal-title":"Cureus"},{"key":"6373_CR4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/TCRM.S117321","volume":"13","author":"M Solmi","year":"2017","unstructured":"Solmi M, Murru A, Pacchiarotti I, Undurraga J, Veronese N, Fornaro M, et al. Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review. Ther Clin Risk Manag. 2017;13:757.","journal-title":"Ther Clin Risk Manag"},{"issue":"1","key":"6373_CR5","first-page":"25","volume":"24","author":"SN Caroff","year":"1988","unstructured":"Caroff SN, Mann SC. Neuroleptic malignant syndrome. Psychopharmacol Bull. 1988;24(1):25\u20139.","journal-title":"Psychopharmacol Bull"},{"issue":"2","key":"6373_CR6","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1176\/ajp.156.2.169","volume":"156","author":"RJ Gurrera","year":"1999","unstructured":"Gurrera RJ. Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome. Am J Psychiatry. 1999;156(2):169\u201380.","journal-title":"Am J Psychiatry"},{"key":"6373_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2026.1718815","volume":"17","author":"O El Oumary","year":"2026","unstructured":"El Oumary O, Laaraj H, Ouhamou M, Mouhadi K, Doufik J, Akebour K, Hamri S, Rammouz I. Case report: atypical neuroleptic malignant syndrome induced by paliperidone palmitate\u2014diagnostic challenges and clinical considerations. Front Psychiatry. 2026;17: 1718815.","journal-title":"Front Psychiatry"},{"issue":"2","key":"6373_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4103\/joacp.JOACP_8_21","volume":"38","author":"G Paul","year":"2021","unstructured":"Paul G, Singhal S, Paul BS, Singh G, Goyal S. Widening spectrum of neuroleptic malignant syndrome: case series. J Anaesthesiol Clin Pharmacol. 2021;38(2):309.","journal-title":"J Anaesthesiol Clin Pharmacol"},{"issue":"9\u201310","key":"6373_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2298\/MPNS1010705C","volume":"63","author":"M Cvjetkovi\u0107-Bosnjak","year":"2010","unstructured":"Cvjetkovi\u0107-Bosnjak M, Soldatovi\u0107-Staji\u0107 B. Side effects of antipsychotic agents\u2013neuroleptic malignant syndrome. Med Pregl. 2010;63(9\u201310):705\u20138.","journal-title":"Med Pregl"},{"issue":"3","key":"6373_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3928\/0048-5713-19910301-10","volume":"21","author":"SC Mann","year":"1991","unstructured":"Mann SC, Caroff SN, Lazarus A. Pathogenesis of neuroleptic malignant syndrome. Psychiatr Ann. 1991;21(3):175\u201380.","journal-title":"Psychiatr Ann"},{"issue":"1","key":"6373_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuron.2016.06.014","volume":"91","author":"G Kharkwal","year":"2016","unstructured":"Kharkwal G, Brami-Cherrier K, Lizardi-Ortiz JE, Nelson AB, Ramos M, Del Barrio D, et al. Parkinsonism driven by antipsychotics originates from dopaminergic control of striatal cholinergic interneurons. Neuron. 2016;91(1):67.","journal-title":"Neuron"},{"issue":"3","key":"6373_CR12","doi-asserted-by":"publisher","first-page":"154","DOI":"10.13104\/imri.2023.0005","volume":"27","author":"HS Jang","year":"2023","unstructured":"Jang HS, Kim KJ, Kong HH, Park Y. Rhabdomyolysis and peripheral neuropathy without compartment syndrome, induced by antipsychotic drug intoxication: a case report. Invest Magn Reson Imaging. 2023;27(3):154\u20137.","journal-title":"Invest Magn Reson Imaging"},{"issue":"2","key":"6373_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/medicina62020378","volume":"62","author":"F \u00d6zdemir","year":"2026","unstructured":"\u00d6zdemir F, Birtane D, Y\u0131lmaz N, \u00c7ukurova Z. Intensive care management and outcomes of neuroleptic malignant syndrome: a single-center retrospective study. Medicina. 2026;62(2): 378.","journal-title":"Medicina"},{"issue":"2","key":"6373_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/jgf2.153","volume":"19","author":"Y Tomoda","year":"2018","unstructured":"Tomoda Y, Kagawa S, Kurata S, Nakatake N, Tanaka K. Tetanus without apparent history of trauma. J Gen Fam Med. 2018;19(2):61.","journal-title":"J Gen Fam Med"},{"key":"6373_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-026-07862-z","author":"L Liu","year":"2026","unstructured":"Liu L, Zhang ZR, Chen CF. Sertraline and quetiapine induced serotonin syndrome and neuroleptic malignant syndrome: a case report. BMC Psychiatry. 2026. https:\/\/doi.org\/10.1186\/s12888-026-07862-z.","journal-title":"BMC Psychiatry"},{"issue":"1","key":"6373_CR16","first-page":"58","volume":"15","author":"PA Torres","year":"2015","unstructured":"Torres PA, Helmstetter JA, Kaye AM, Kaye AD. Rhabdomyolysis: Pathogenesis, Diagnosis, and Treatment. Ochsner J. 2015;15(1):58.","journal-title":"Ochsner J"},{"issue":"2","key":"6373_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/cc2978","volume":"9","author":"ALVJMP Huerta-Alard\u00edn","year":"2005","unstructured":"Huerta-Alard\u00edn ALVJMP. review: rhabdomyolysis\u2014an overview for clinicans. Bench-to-bedside Crit Care. 2005;9(2):158\u201369.","journal-title":"Bench-to-bedside Crit Care"},{"key":"6373_CR18","doi-asserted-by":"publisher","first-page":"e924347","DOI":"10.12659\/AJCR.924347","volume":"21","author":"P Hansrivijit","year":"2020","unstructured":"Hansrivijit P, Yarlagadda K, Puthenpura MM, Cunningham JM. Extremely High Creatine Kinase Activity in Rhabdomyolysis without Acute Kidney Injury. Am J Case Rep. 2020;21:e924347\u201351.","journal-title":"Am J Case Rep"},{"issue":"4","key":"6373_CR19","first-page":"302","volume":"10","author":"C Rosenberry","year":"2009","unstructured":"Rosenberry C, Stone F, Kalbfleisch K. Rhabdomyolysis-Induced Severe Hyperkalemia. Western J Emerg Med. 2009;10(4):302.","journal-title":"Western J Emerg Med"},{"issue":"4","key":"6373_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00019052-199408000-00013","volume":"7","author":"J Kornhuber","year":"1994","unstructured":"Kornhuber J, Weller M. Neuroleptic malignant syndrome. Curr Opin Neurol. 1994;7(4):353\u20137.","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"6373_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF03160978","volume":"5","author":"E Morris","year":"2009","unstructured":"Morris E, Green D, Graudins A. Neuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine. J Med Toxicol. 2009;5(1):27\u201331.","journal-title":"J Med Toxicol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06373-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06373-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06373-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:55:37Z","timestamp":1791413737000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06373-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6373"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06373-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"At our institute, ethical approval is not required for the publication of case reports; therefore, our hospital is exempt from this requirement, and informed written consent was obtained from the patient to use their information and publish the case report, ensuring that identifying data remains anonymous.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"602"}}